Market Cap 796.42B
Revenue (ttm) 45.04B
Net Income (ttm) 10.59B
EPS (ttm) N/A
PE Ratio 56.53
Forward PE 31.43
Profit Margin 23.51%
Debt to Equity Ratio 2.00
Volume 10,853,300
Avg Vol 3,788,262
Day's Range N/A - N/A
Shares Out 948.17M
Stochastic %K 90%
Beta 0.51
Analysts Strong Sell
Price Target $1,019.43

Latest News on LLY

Eli Lilly: A New Leader In Weight Loss Drugs Is Clearly Emerging

Apr 20, 2025, 9:00 AM EDT - 18 hours ago

Eli Lilly: A New Leader In Weight Loss Drugs Is Clearly Emerging


Eli Lilly jumps on GLP-1 pill trial success

Apr 17, 2025, 6:17 PM EDT - 3 days ago

Eli Lilly jumps on GLP-1 pill trial success


Eli Lilly's weight-loss pill: What it means for the sector

Apr 17, 2025, 5:13 PM EDT - 3 days ago

Eli Lilly's weight-loss pill: What it means for the sector


Lilly reports positive phase 3 trial results for GLP-1 pill

Apr 17, 2025, 10:29 AM EDT - 3 days ago

Lilly reports positive phase 3 trial results for GLP-1 pill


Lilly pill leads to 7.9% weight loss at 40 weeks in trial

Apr 17, 2025, 6:50 AM EDT - 3 days ago

Lilly pill leads to 7.9% weight loss at 40 weeks in trial


Healthcare Stocks Aren't a Shelter From the Tariff Storm

Apr 9, 2025, 12:04 PM EDT - 11 days ago

Healthcare Stocks Aren't a Shelter From the Tariff Storm

BMY PFE XLV


NVDA & INTC Behind AMD Downgrade, WFC & LLY Upgrades

Apr 8, 2025, 10:30 AM EDT - 12 days ago

NVDA & INTC Behind AMD Downgrade, WFC & LLY Upgrades

AMD INTC NVDA WFC